Device Trial Radar · NCT05755516
Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms
Last checked: Nov 20, 2026Latest source record: Jan 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
204
Actual
Start
Feb 14, 2023
Primary completion
Mar 10, 2024
Study completion Dec 13, 2024
Sponsor
- Lead sponsor
- Ton-Bridge Medical Tech. Co., LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 6, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy and safety of Self-expanding Intracranial Stent (Tonbridge), by comparing the data obtained from Self-expanding Intracranial Stent (Zhuhai Tonbridge Medical Tech. Co., Ltd.) and LVIS/LVIS Jr. (MicroVention Europe SARL) for endovascular treatment of intracranial aneurysms.
Conditions
- Intracranial Aneurysm
Interventions
Self-expanding Intracranial Stent (Tonbridge)Device
Stent assisted coiling with Self-expanding Intracranial Stent (Tonbridge).
LVIS and LVIS Jr. (MicroVention)Device
Stent assisted coiling with LVIS and LVIS Jr. (MicroVention).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Successful occlusion rate of aneurysms at 6 monthsTime frame: 6 months±30 days post-procedure
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
Changhai Hospital of Shanghai
Shanghai, China
The First Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.